"Precision medicine" is allowing us to analyse a person's genetic makeup and target treatments based on their specific needs.
It's exciting to think we're on the brink of a genomic revolution in health care. But just because new technology becomes available, it doesn't mean it should automatically be publicly funded.
CRISPR harnesses the natural defence mechanisms of some bacteria to cut human DNA strands. Then the DNA strand either heals itself or we inject new DNA to mend the gap. This is gene editing.
In 2030, there is a boom in precision medicine, where diseases – from cancer to dementia – are defined and targeted more specifically with a focus on their molecular makeup.